{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:49:37Z","timestamp":1792154977824,"version":"4.4.0"},"reference-count":99,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>The clinical management of gastric cancer is challenged by profound tumor heterogeneity and the emergence of drug-resistant cell populations. Ferroptosis, a regulated form of iron-dependent cell death driven by lipid peroxidation, has exhibited limited clinical efficacy as a monotherapy. Emerging evidence shows that selective autophagy pathways can promote ferroptosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In this study, integrated analysis of ferroptosis-associated autophagy genes (FARGs) was conducted to explore their application potential in improving therapeutic outcomes. By leveraging transcriptomic and clinical data from The Cancer Genome Atlas and Gene Expression Omnibus databases, a prognostic model was developed using univariate Cox regression followed by Least Absolute Shrinkage and Selection Operator (LASSO) regression, which identified 11 FARGs exhibiting robust prognostic performance across multiple cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Functional enrichment analysis revealed distinct pathway activations: extracellular matrix remodeling was enriched in high-risk patients, whereas interferon-mediated immune responses were heightened in low-risk patients. Further tumor microenvironment characterization revealed that high-risk patients displayed an immunosuppressive phenotype marked by M2 macrophage infiltration, upregulation of immune checkpoint molecules, and elevated stromal activity. By contrast, low-risk patients were associated with a higher prevalence of microsatellite instability-high status and increased tumor mutational burden, which are biomarkers predictive of favorable responses to immune checkpoint inhibitors. Investigation into autophagy\u2013ferroptosis crosstalk highlighted the central role of lipid metabolism\u2013related pathways. Aldehyde dehydrogenase 3A2 was also identified as a key biomarker, and functional validation confirmed its involvement in promoting cancer cell proliferation and migration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Collectively, the FARG-based model developed here shows great application potential in stratifying patient responses to immunotherapy and developing personalized treatment strategies for gastric cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_2467_25","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:00:23Z","timestamp":1790766023000},"page":"659-673","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic and immunotherapeutic efficacy predictive model for gastric cancer based on ferroptosis- and autophagy-related genes"],"prefix":"10.4103","volume":"22","author":[{"given":"Chuanyu","family":"Leng","sequence":"first","affiliation":[{"name":"Department of Oncology, The Affiliated Hospital of Qingdao University, Shinan District, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Hospital of Qingdao University, Shinan District, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensheng","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Hospital of Qingdao University, Shinan District, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Hospital of Qingdao University, Shinan District, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Hospital of Qingdao University, Shinan District, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Hospital of Qingdao University, Shinan District, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Hospital of Qingdao University, Shinan District, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Hospital of Qingdao University, Shinan District, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"R1-20261016","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R2-20261016","first-page":"209","article-title":"Global Cancer Statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R3-20261016","first-page":"264","article-title":"Current treatment and recent progress in gastric cancer","volume":"71","author":"Joshi","year":"2021","journal-title":"CA Cancer J Clini"},{"key":"R4-20261016","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4103\/jcrt.jcrt_1718_22","article-title":"Postoperative chemoradiotherapy in patients with locally advanced gastric cancer with poor pathologic response to neoadjuvant chemotherapy","volume":"20","author":"Gal","year":"2024","journal-title":"J Cancer Res Ther"},{"key":"R5-20261016","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: Mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R6-20261016","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"R7-20261016","doi-asserted-by":"crossref","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","article-title":"Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis","volume":"113","author":"Yang","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"R8-20261016","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/0006-291X(79)92115-6","article-title":"The autoxidation of arachidonic acid: Formation of the proposed SRS-A intermediate","volume":"89","author":"Porter","year":"1979","journal-title":"Biochem Biophys Res Commun"},{"key":"R9-20261016","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0167-7799(97)01076-7","article-title":"Polyunsaturated fatty acids, Part 1: Occurrence, biological activities and applications","volume":"15","author":"Gill","year":"1997","journal-title":"Trends Biotechnol"},{"key":"R10-20261016","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"R11-20261016","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41589-020-0472-6","article-title":"Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis","volume":"16","author":"Zou","year":"2020","journal-title":"Nat Chem Biol"},{"key":"R12-20261016","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.molmed.2014.10.009","article-title":"Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway","volume":"21","author":"Ohaegbulam","year":"2015","journal-title":"Trends Mol Med"},{"key":"R13-20261016","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/s41589-019-0408-1","article-title":"The chemical basis of ferroptosis","volume":"15","author":"Conrad","year":"2019","journal-title":"Nat Chem Biol"},{"key":"R14-20261016","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.physiol.69.031905.164337","article-title":"Iron homeostasis","volume":"69","author":"Andrews","year":"2007","journal-title":"Annu Rev Physiol"},{"key":"R15-20261016","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/cr.2016.95","article-title":"Ferroptosis is an autophagic cell death process","volume":"26","author":"Gao","year":"2016","journal-title":"Cell Res"},{"key":"R16-20261016","doi-asserted-by":"crossref","first-page":"e51031","DOI":"10.7554\/eLife.51031","article-title":"Impaired lysosomal acidification triggers iron deficiency and inflammation in vivo","volume":"8","author":"Yambire","year":"2019","journal-title":"Elife"},{"key":"R17-20261016","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: Opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J Hematol Oncol"},{"key":"R18-20261016","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.1416","article-title":"The role of iron and reactive oxygen species in cell death","volume":"10","author":"Dixon","year":"2014","journal-title":"Nat Chem Biol"},{"key":"R19-20261016","doi-asserted-by":"crossref","first-page":"175913","DOI":"10.1016\/j.ejphar.2023.175913","article-title":"Understanding sorafenib-induced ferroptosis and resistance mechanisms: Implications for cancer therapy","volume":"955","author":"Li","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"R20-20261016","first-page":"143","article-title":"Lipid peroxidation-dependent cell death regulated by GP\u00d74 and ferroptosis","volume":"403","author":"Imai","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"key":"R21-20261016","first-page":"23","article-title":"Curcumenol triggered ferroptosis in lung cancer cells via lncRNA H19\/miR-19b-3p\/FTH1 axis","volume":"13","author":"Zhang","year":"2021","journal-title":"Bioact Mater"},{"key":"R22-20261016","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s10020-023-00730-6","article-title":"Resveratrol reduces ROS-induced ferroptosis by activating SIRT3 and compensating the GSH\/GPX4 pathway","volume":"29","author":"Wang","year":"2023","journal-title":"Mol Med"},{"key":"R23-20261016","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40880-018-0288-x","article-title":"Amino acid transporter SLC7A11\/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer","volume":"38","author":"Koppula","year":"2018","journal-title":"Cancer Commun (Lond)"},{"key":"R24-20261016","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrd4002","article-title":"Modulation of oxidative stress as an anticancer strategy","volume":"12","author":"Gorrini","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"R25-20261016","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: Ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"key":"R26-20261016","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1080\/15548627.2023.2170960","article-title":"ATM orchestrates ferritinophagy and ferroptosis by phosphorylating NCOA4","volume":"19","author":"Wu","year":"2023","journal-title":"Autophagy"},{"key":"R27-20261016","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.semcancer.2019.03.002","article-title":"Ferroptosis is a type of autophagy-dependent cell death","volume":"66","author":"Zhou","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"R28-20261016","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","article-title":"Autophagy and autophagy-related pathways in cancer","volume":"24","author":"Debnath","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R29-20261016","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.cell.2007.10.048","article-title":"Growth arrest and autophagy are required for salivary gland cell degradation in Drosophila","volume":"131","author":"Berry","year":"2007","journal-title":"Cell"},{"key":"R30-20261016","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13046-020-01620-z","article-title":"BDH2 triggers ROS-induced cell death and autophagy by promoting Nrf2 ubiquitination in gastric cancer","volume":"39","author":"Liu","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"R31-20261016","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","article-title":"Autophagy promotes ferroptosis by degradation of ferritin","volume":"12","author":"Hou","year":"2016","journal-title":"Autophagy"},{"key":"R32-20261016","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41593-021-00862-0","article-title":"Genome-wide CRISPRi\/a screens in human neurons link lysosomal failure to ferroptosis","volume":"24","author":"Tian","year":"2021","journal-title":"Nat Neurosci"},{"key":"R33-20261016","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.cub.2018.05.094","article-title":"AMPK-mediated BECN1 phosphorylation promotes ferroptosis by directly blocking system X (c)(-) activity","volume":"28","author":"Song","year":"2018","journal-title":"Curr Biol"},{"key":"R34-20261016","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.chembiol.2020.02.005","article-title":"Autophagy-dependent ferroptosis: Machinery and regulation","volume":"27","author":"Liu","year":"2020","journal-title":"Cell Chem Biol"},{"key":"R35-20261016","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.bbrc.2018.12.039","article-title":"Lipid storage and lipophagy regulates ferroptosis","volume":"508","author":"Bai","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"R36-20261016","doi-asserted-by":"crossref","first-page":"eaaw2238","DOI":"10.1126\/sciadv.aaw2238","article-title":"Clockophagy is a novel selective autophagy process favoring ferroptosis","volume":"5","author":"Yang","year":"2019","journal-title":"Sci Adv"},{"key":"R37-20261016","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/aps.2013.5","article-title":"Application and interpretation of current autophagy inhibitors and activators","volume":"34","author":"Yang","year":"2013","journal-title":"Acta Pharmacol Sin"},{"key":"R38-20261016","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jare.2024.09.027","article-title":"Salidroside sensitizes Triple-negative breast cancer to ferroptosis by SCD1-mediated lipogenesis and NCOA4-mediated ferritinophagy","volume":"74","author":"Huang","year":"2025","journal-title":"J Adv Res"},{"key":"R39-20261016","doi-asserted-by":"crossref","first-page":"10207","DOI":"10.1021\/acsnano.4c17344","article-title":"Assembling ruthenium complexes to form ruthenosome unleashing ferritinophagy-mediated tumor suppression","volume":"19","author":"Meng","year":"2025","journal-title":"ACS Nano"},{"key":"R40-20261016","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.3390\/molecules15031378","article-title":"Biological actions of artemisinin: Insights from medicinal chemistry studies","volume":"15","author":"Li","year":"2010","journal-title":"Molecules"},{"key":"R41-20261016","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/s41467-018-04179-8","article-title":"Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype","volume":"9","author":"Oh","year":"2018","journal-title":"Nat Commun"},{"key":"R42-20261016","doi-asserted-by":"crossref","first-page":"1.30.1","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards Suite: From gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr Protoc Bioinformatics"},{"key":"R43-20261016","first-page":"243","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT","author":"Chen","year":"2018","journal-title":"Methods Mol Biol 2018"},{"key":"R44-20261016","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of drug sensitivity in cancer (GDSC): A resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"R45-20261016","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pharmthera.2018.04.004","article-title":"DNA mismatch repair in cancer","volume":"189","author":"Baretti","year":"2018","journal-title":"Pharmacol Ther"},{"key":"R46-20261016","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"R47-20261016","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep"},{"key":"R48-20261016","first-page":"409","article-title":"Cancer treatment and survivorship statistics, 2022","volume":"72","author":"Miller","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"R49-20261016","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: Recent progress and future perspectives","volume":"16","author":"Guan","year":"2023","journal-title":"J Hematol Oncol"},{"key":"R50-20261016","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/cac2.12516","article-title":"The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023","volume":"44","author":"Wang","year":"2024","journal-title":"Cancer Commun (Lond)"},{"key":"R51-20261016","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","article-title":"Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy","volume":"7","author":"Gao","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"R52-20261016","doi-asserted-by":"crossref","first-page":"101170","DOI":"10.1016\/j.drup.2024.101170","article-title":"Autophagy in cancer development, immune evasion, and drug resistance","volume":"78","author":"Niu","year":"2025","journal-title":"Drug Resist Updat"},{"key":"R53-20261016","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: Molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res"},{"key":"R54-20261016","doi-asserted-by":"crossref","first-page":"20573","DOI":"10.1002\/cam4.6623","article-title":"Metabolic reprogramming, autophagy, and ferroptosis: Novel arsenals to overcome immunotherapy resistance in gastrointestinal cancer","volume":"12","author":"Wang","year":"2023","journal-title":"Cancer Med"},{"key":"R55-20261016","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/ars.2022.0202","article-title":"Autophagy-dependent ferroptosis in cancer","volume":"39","author":"Chen","year":"2023","journal-title":"Antioxid Redox Signal"},{"key":"R56-20261016","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12967-024-06059-w","article-title":"Crosstalk between ferroptosis and autophagy: Broaden horizons of cancer therapy","volume":"23","author":"Liu","year":"2025","journal-title":"J Transl Med"},{"key":"R57-20261016","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12943-024-02217-2","article-title":"Ferroptosis and pyroptosis are connected through autophagy: A new perspective of overcoming drug resistance","volume":"24","author":"Zhao","year":"2025","journal-title":"Mol Cancer"},{"key":"R58-20261016","doi-asserted-by":"crossref","first-page":"1377472","DOI":"10.3389\/fimmu.2024.1377472","article-title":"Development and verification of a manganese metabolism- and immune-related genes signature for prediction of prognosis and immune landscape in gastric cancer","volume":"15","author":"Han","year":"2024","journal-title":"Front Immunol"},{"key":"R59-20261016","doi-asserted-by":"crossref","first-page":"1509771","DOI":"10.3389\/fonc.2025.1509771","article-title":"A prognostic model based on autophagy-and senescence-related genes for gastric cancer: Implications for immunotherapy and personalized treatment","volume":"15","author":"Chen","year":"2025","journal-title":"Front Oncol"},{"key":"R60-20261016","doi-asserted-by":"crossref","first-page":"1327565","DOI":"10.3389\/fimmu.2024.1327565","article-title":"Progressions of the correlation between lipid metabolism and immune infiltration characteristics in gastric cancer and identification of BCHE as a potential biomarker","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"R61-20261016","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.trecan.2019.10.007","article-title":"Metabolic regulation of macrophage polarization in cancer","volume":"5","author":"Mehla","year":"2019","journal-title":"Trends Cancer"},{"key":"R62-20261016","doi-asserted-by":"crossref","first-page":"e2002054","DOI":"10.1002\/adma.202002054","article-title":"Engineering macrophages for cancer immunotherapy and drug delivery","volume":"32","author":"Xia","year":"2020","journal-title":"Adv Mater"},{"key":"R63-20261016","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"R64-20261016","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s43018-025-00909-2","article-title":"Linking macrophage metabolism to function in the tumor microenvironment","volume":"6","author":"Jin","year":"2025","journal-title":"Nat Cancer"},{"key":"R65-20261016","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"R66-20261016","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13045-021-01053-x","article-title":"Novel therapies emerging in oncology to target the TGF-\u03b2 pathway","volume":"14","author":"Kim","year":"2021","journal-title":"J Hematol Oncol"},{"key":"R67-20261016","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/j.ymthe.2021.02.016","article-title":"Imbalance of TGF-\u03b21\/BMP-7 pathways induced by M2-polarized macrophages promotes hepatocellular carcinoma aggressiveness","volume":"29","author":"Ning","year":"2021","journal-title":"Mol Ther"},{"key":"R68-20261016","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.3390\/ijms20112767","article-title":"TGF-\u03b2-mediated epithelial-mesenchymal transition and cancer metastasis","volume":"20","author":"Hao","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R69-20261016","doi-asserted-by":"crossref","first-page":"786728","DOI":"10.3389\/fcell.2021.786728","article-title":"TGF-\u03b2 signaling and resistance to cancer therapy","volume":"9","author":"Zhang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R70-20261016","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fcell.2020.00123","article-title":"Diverse role of Tgf-\u03b2 in kidney disease","volume":"8","author":"Gu","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"R71-20261016","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ccell.2025.03.015","article-title":"Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion","volume":"43","author":"Zhu","year":"2025","journal-title":"Cancer Cell"},{"key":"R72-20261016","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41568-025-00810-1","article-title":"Phosphoinositide kinases in cancer: From molecular mechanisms to therapeutic opportunities","volume":"25","author":"Llorente","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"R73-20261016","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00432-022-04408-0","article-title":"Predictive biomarkers in gastric cancer","volume":"149","author":"R\u00f6cken","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"R74-20261016","doi-asserted-by":"crossref","first-page":"624","DOI":"10.4103\/jcrt.jcrt_655_24","article-title":"Impact of clinicopathological factors and treatment outcomes on gastric cancer survival: A tertiary care hospital-based study in Eastern India","volume":"21","author":"Ghosh","year":"2025","journal-title":"J Cancer Res Ther"},{"key":"R75-20261016","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s10120-024-01505-6","article-title":"Claudin-18 status and its correlation with HER2 and PD-L1 expression in gastric cancer with peritoneal dissemination","volume":"27","author":"Ogawa","year":"2024","journal-title":"Gastric Cancer"},{"key":"R76-20261016","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","article-title":"Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer","volume":"24","author":"Kim","year":"2018","journal-title":"Nat Med"},{"key":"R77-20261016","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1007\/s00262-023-03520-5","article-title":"PD-1 and PD-L1 inhibitors in cold colorectal cancer: Challenges and strategies","volume":"72","author":"Lin","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"R78-20261016","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s13046-019-1259-z","article-title":"Combination of CTLA-4 and PD-1 blockers for treatment of cancer","volume":"38","author":"Rotte","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"R79-20261016","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3390\/curroncol29030131","article-title":"Immunotherapy in Gastric Cancer","volume":"29","author":"H\u00f6gner","year":"2022","journal-title":"Curr Oncol"},{"key":"R80-20261016","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol Cancer"},{"key":"R81-20261016","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4103\/jcrt.jcrt_2040_22","article-title":"Complete and rapid response with the combination of immunotherapy and chemotherapy in a young adult patient with microsatellite instability-high metastatic gastric cancer","volume":"20","author":"Kazaz","year":"2024","journal-title":"J Cancer Res Ther"},{"key":"R82-20261016","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N Engl J Med"},{"key":"R83-20261016","doi-asserted-by":"crossref","first-page":"e003777","DOI":"10.1136\/jitc-2021-003777","article-title":"Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient\/microsatellite instability-high (dMMR\/MSI-H) or proficient\/stable (MMRp\/MSS) endometrial cancer: Interim results from GARNET-a phase I, single-arm study","volume":"10","author":"Oaknin","year":"2022","journal-title":"J Immunother Cancer"},{"key":"R84-20261016","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.7150\/ijbs.71714","article-title":"The role of DNA mismatch repair in immunotherapy of human cancer","volume":"18","author":"He","year":"2022","journal-title":"Int J Biol Sci"},{"key":"R85-20261016","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejca.2022.07.020","article-title":"Deficient mismatch repair\/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment","volume":"175","author":"Taieb","year":"2022","journal-title":"Eur J Cancer"},{"key":"R86-20261016","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/annonc\/mdz116","article-title":"ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1\/PD-L1 expression and tumour mutational burden: A systematic review-based approach","volume":"30","author":"Luchini","year":"2019","journal-title":"Ann Oncol"},{"key":"R87-20261016","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.annonc.2024.03.007","article-title":"Tumor mutational burden for the prediction of PD-(L) 1 blockade efficacy in cancer: Challenges and opportunities","volume":"35","author":"Wang","year":"2024","journal-title":"Ann Oncol"},{"key":"R88-20261016","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.engmed.2025.100092","article-title":"Biomaterial-mediated modulation of tumor microenvironment and therapeutic sensitization","volume":"2","author":"Qiao","year":"2025","journal-title":"EngMedicine"},{"key":"R89-20261016","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12943-019-1091-2","article-title":"Novel immune checkpoint targets: Moving beyond PD-1 and CTLA-4","volume":"18","author":"Qin","year":"2019","journal-title":"Mol Cancer"},{"key":"R90-20261016","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13046-021-01987-7","article-title":"Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer","volume":"40","author":"Zhang","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"R91-20261016","doi-asserted-by":"crossref","first-page":"100336","DOI":"10.1016\/j.esmoop.2021.100336","article-title":"Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers","volume":"7","author":"Palmeri","year":"2022","journal-title":"ESMO Open"},{"key":"R92-20261016","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","article-title":"Ferroptosis at the intersection of lipid metabolism and cellular signaling","volume":"82","author":"Liang","year":"2022","journal-title":"Mol Cell"},{"key":"R93-20261016","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","article-title":"Ferroptosis: Mechanisms and links with diseases","volume":"6","author":"Yan","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"R94-20261016","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.tcb.2023.05.003","article-title":"Regulation of ferroptosis by lipid metabolism","volume":"33","author":"Pope","year":"2023","journal-title":"Trends Cell Biol"},{"key":"R95-20261016","doi-asserted-by":"crossref","first-page":"11695","DOI":"10.3390\/ijms231911695","article-title":"ALDH3A2, ODF2, QSOX2, and MicroRNA-503-5p expression to forecast recurrence in TMPRSS2-ERG-positive prostate cancer","volume":"23","author":"Kobelyatskaya","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R96-20261016","doi-asserted-by":"crossref","first-page":"147515","DOI":"10.1016\/j.gene.2023.147515","article-title":"Inhibit ALDH3A2 reduce ovarian cancer cells survival via elevating ferroptosis sensitivity","volume":"876","author":"Dong","year":"2023","journal-title":"Gene"},{"key":"R97-20261016","doi-asserted-by":"crossref","first-page":"111622","DOI":"10.1016\/j.cbi.2025.111622","article-title":"Dual roles and therapeutic potential of ALDH3 family members in cancer","volume":"418","author":"Liu","year":"2025","journal-title":"Chem Biol Interact"},{"key":"R98-20261016","doi-asserted-by":"crossref","first-page":"101835","DOI":"10.1016\/j.tranon.2023.101835","article-title":"miR-1182-mediated ALDH3A2 inhibition affects lipid metabolism and progression in ccRCC by activating the PI3K-AKT pathway","volume":"40","author":"Lv","year":"2024","journal-title":"Transl Oncol"},{"key":"R99-20261016","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/asj.13225","article-title":"Potential role of ALDH3A2 on the lipid and glucose metabolism regulated by (-)-hydroxycitric acid in chicken embryos","volume":"90","author":"Li","year":"2019","journal-title":"Anim Sci J"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2467_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:01:47Z","timestamp":1792152107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2467_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":99,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_2467_25","relation":{},"ISSN":["1998-4138","0973-1482"],"issn-type":[{"value":"1998-4138","type":"print"},{"value":"0973-1482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2025-12-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}